Diagnostic utility of anti-Saccharomyces cerevisiae antibody (ASCA) and Interferon-γ assay in the differential diagnosis of Crohn's disease and intestinal tuberculosis.
暂无分享,去创建一个
Young Sook Park | J. S. Kim | C. Choi | B. Jang | B. Ye | Y. Jeen | Y. Choi | D. Han | S. Jung | Suk-Kyun Yang | J. Cheon | W. Kim | B. Kim | You Sun Kim | J. Choi | Young-Ho Kim
[1] J. S. Kim,et al. Prospective evaluation of the clinical utility of interferon‐&ggr; assay in the differential diagnosis of intestinal tuberculosis and Crohn's disease , 2011, Inflammatory bowel diseases.
[2] C. Bowlus,et al. The geoepidemiology of autoimmune intestinal diseases. , 2010, Autoimmunity reviews.
[3] G. Gherardi,et al. Experience with two cases of intestinal tuberculosis: utility of the QuantiFERON-TB Gold test for diagnosis. , 2008, Surgical infections.
[4] G. Rook,et al. In situ PCR for Mycobacterium tuberculosis in endoscopic mucosal biopsy specimens of intestinal tuberculosis and Crohn disease. , 2008, American journal of clinical pathology.
[5] D. Amarapurkar,et al. Diagnosis of Crohn's disease in India where tuberculosis is widely prevalent. , 2008, World journal of gastroenterology.
[6] S. Edwards,et al. Microbial mannan inhibits bacterial killing by macrophages: a possible pathogenic mechanism for Crohn's disease. , 2007, Gastroenterology.
[7] U. Ghoshal,et al. Anti-Saccharomyces cerevisiae antibody is not useful to differentiate between Crohn's disease and intestinal tuberculosis in India. , 2007, Journal of postgraduate medicine.
[8] J. H. Kim,et al. Clinical significance of anti-Saccharomyces cerevisiae antibody (ASCA) in Korean patients with Crohn's disease and its relationship to the disease clinical course. , 2007, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.
[9] D. Epstein,et al. Review article: the diagnosis and management of Crohn’s disease in populations with high‐risk rates for tuberculosis , 2007, Alimentary pharmacology & therapeutics.
[10] M. Pentecost,et al. Role of colonoscopic biopsy in distinguishing between Crohn’s disease and intestinal tuberculosis , 2006, Journal of Clinical Pathology.
[11] K-J Kim,et al. Analysis of colonoscopic findings in the differential diagnosis between intestinal tuberculosis and Crohn's disease. , 2006, Endoscopy.
[12] C. Dye. Global epidemiology of tuberculosis , 2006, The Lancet.
[13] X. Bossuyt. Serologic markers in inflammatory bowel disease. , 2006, Clinical chemistry.
[14] P. Rutgeerts,et al. Saccharomyces boulardii in Crohn's disease: effect on anti-Saccharomyces cerevisiae antibodies and intestinal permeability. , 2005, Inflammatory bowel diseases.
[15] R. Balicer,et al. Anti-Saccharomyces cerevisiae and antineutrophil cytoplasmic antibodies as predictors of inflammatory bowel disease , 2005, Gut.
[16] L. Jeyaseelan,et al. Segmental colonoscopic biopsies in the differentiation of ileocolic tuberculosis from Crohn's disease , 2005, Journal of gastroenterology and hepatology.
[17] A. Duhamel,et al. Anti-Saccharomyces cerevisiae antibodies in twins with inflammatory bowel disease , 2005, Gut.
[18] M. Wong,et al. Tuberculosis at Chris Hani Baragwanath Hospital: numbers of patients diagnosed and outcomes of referrals to district clinics. , 2005, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.
[19] H. Drummond,et al. Anti‐Saccharomyces cerevisiae antibodies (ASCA) in Crohn's disease are associated with disease severity but not NOD2/CARD15 mutations , 2004, Clinical and experimental immunology.
[20] W. Reinisch,et al. Do high serum levels of anti-Saccharomyces cerevisiae antibodies result from a leakiness of the gut barrier in Crohn's disease? , 2003, European journal of gastroenterology & hepatology.
[21] Ji Won Kim,et al. [Clinical features and therapeutic responses of perianal lesions in Crohn's disease]. , 2003, The Korean journal of gastroenterology = Taehan Sohwagi Hakhoe chi.
[22] D. Chang,et al. Epidemiology of inflammatory bowel disease in the Songpa‐Kangdong district, Seoul, Korea, 1986–2005: A KASID study , 2003, Inflammatory bowel diseases.
[23] R. Long,et al. Anti-tumour necrosis factor agents and tuberculosis risk: mechanisms of action and clinical management. , 2003, The Lancet. Infectious diseases.
[24] J. S. Kim,et al. Diagnostic Role of Anti-Saccharomyces cerevisiae Mannan Antibodies Combined With Antineutrophil Cytoplasmic Antibodies in Patients With Inflammatory Bowel Disease , 2002, Diseases of the colon and rectum.
[25] Suk-Kyun Yang. Current Status and Clinical Characteristics of Inflammatory Bowel Disease in Korea , 2002 .
[26] P. Rutgeerts,et al. Comparative study of ASCA (Anti-Saccharomyces cerevisiae antibody) assays in inflammatory bowel disease. , 2001, Gastroenterology.
[27] P. Rutgeerts,et al. Diagnostic value of anti-Saccharomyces cerevisiae and antineutrophil cytoplasmic autoantibodies in inflammatory bowel disease , 2001, American Journal of Gastroenterology.
[28] T. Matsui,et al. Crohn's disease in Japan , 2000, Diseases of the colon and rectum.
[29] S. Targan,et al. Marker antibody expression stratifies Crohn's disease into immunologically homogeneous subgroups with distinct clinical characteristics , 2000, Gut.
[30] M. Mathan,et al. Endoscopic mucosal biopsies are useful in distinguishing granulomatous colitis due to Crohn’s disease from tuberculosis , 1999, Gut.
[31] S. Targan,et al. Diagnostic accuracy of serological assays in pediatric inflammatory bowel disease. , 1998, Gastroenterology.
[32] S. Targan,et al. Anti-Saccharomyces cerevisiae mannan antibodies combined with antineutrophil cytoplasmic autoantibodies in inflammatory bowel disease: prevalence and diagnostic role , 1998, Gut.
[33] P. Jacquinot,et al. Specific antibody response to oligomannosidic epitopes in Crohn's disease , 1996, Clinical and diagnostic laboratory immunology.
[34] S. Chari,et al. Does Crohn's disease need differentiation from tuberculosis? , 1996, Journal of gastroenterology and hepatology.
[35] S. Allan,et al. Identification of a 200-kDa glycoprotein antigen of Saccharomyces cerevisiae. , 1991, Immunology letters.
[36] J. Main,et al. Antibody to selected strains of Saccharomyces cerevisiae (baker's and brewer's yeast) and Candida albicans in Crohn's disease. , 1990, Gut.
[37] M. Kerr,et al. Antibody to Saccharomyces cerevisiae (bakers' yeast) in Crohn's disease. , 1988, BMJ.
[38] Rajiva Gupta,et al. Anti-Saccharomyces cerevisiae Antibody Does Not Differentiate Between Crohn's Disease and Intestinal Tuberculosis , 2006, Digestive Diseases and Sciences.
[39] G. Lee,et al. [Clinical characteristics at diagnosis and course of Korean patients with Crohn's disease]. , 2004, The Korean journal of gastroenterology = Taehan Sohwagi Hakhoe chi.